Rapid Sterile Connections for Biopharm Processing - Tutorial: Disposable Systems Enable Safer Sterile Connections

摘要

In 2003, the U.S. Department of Commerce reported more than 370 biotech drugs and vaccines were in clinical trials in the United States. Seventy percent of the FDA-approved biotechnology drugs and vaccines were approved in just the last six. years. Asthe number and complexity of drugs in the R&D pipeline reach an all-time high, production demands are placing steady pressure on current manufacturing capacities. Many biopharm manufacturers are under pressure to increase production capabilities and efficiencies. To meet growing production demands, single-use disposable systems can provide a competitive advantage in drug development and processing.